Health and Human Services (HHS) - Wide Procurement of Biosafety Level 4 (BSL-4) Suits- Personal Protective Equipment
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
NATIONAL INSTITUTES OF HEALTH OLAO
Contract Value
Not provided
Codes & Classification
Solicitation Number
R75N98026Q00738
NAICS
339999 - All Other Miscellaneous Manufacturing
Classification Code
6640
Additional Details
Documents2
The Department of Health and Human Services (HHS), through the National Institutes of Health (NIH) Office of Logistics and Acquisition Operations (OLAO), has issued a combined synopsis/solicitation for the procurement of multiple models of Biosafety Level 4 (BSL-4) Positive Pressure Suits. This acquisition is intended to support the critical safety needs of personnel and researchers at both the NIH and the Centers for Disease Control and Prevention (CDC) who operate within high-containment BSL-4 laboratory environments. These facilities routinely handle high-risk pathogens and deadly biological agents, necessitating the highest standards of personal protective equipment.
The procurement is structured as a sole-source, firm-fixed-price purchase order to Protective Industrial Products, Inc., with an estimated total value of $3,075,975, inclusive of all options. The anticipated award date is no later than August 17, 2026, with a base period and two option years extending through August 16, 2029, should all options be exercised. The place of performance is Latham, New York.
This requirement is specifically for Honeywell brand BSL-4 positive pressure suits, as these are the only products that meet the stringent and unique operational and safety requirements of the NIH and CDC BSL-4 laboratories. The Honeywell suits are uniquely compatible with the existing laboratory infrastructure and are the only models that satisfy all salient characteristics necessary for these high-risk environments.
Key requirements for the BSL-4 suits include:
- The ability to supply approximately 200 suits per year to meet NIH facility demands.
- Durability for repeated use without defects.
- Chemical compatibility with disinfectants used in BSL-4 labs, ensuring no material degradation.
- Availability in at least five distinct sizes (S, M, L, XL, 2XL) to accommodate diverse personnel.
- Breathing airline placement that aligns with human physiology and supports a flow rate of 16-34 CFM.
- Airline specifications compatible with NIH BSL-4 facility designs (80-100 psi maximum, 60 psi operational set point).
- Exhaust valves that are protected from direct chemical or hazardous liquid splashes, automatically seal upon air disconnection, and include internal screens for added protection.
- Suit gloves that interface securely with the suit and are compatible with gloves currently in use at NIH BSL-4 facilities.
- Inclusion of an internal HEPA filter on the breathing air line.
- Light-colored material to facilitate visibility of contamination or splashes.
- Smooth seams for effective decontamination and absence of excess fabric.
- Internal temperature not exceeding 26°C during continuous use for up to five hours.
- Two footwear options: attached outer boot or stocking feet for use with external shoes.
- Minimum shelf life of five years.
- Design that allows for quantitative pressure decay testing to verify suit integrity.
- Visor or headpiece providing 300 degrees of transparency for optimal visibility.
- Suit weight not exceeding 10 lbs. to minimize user fatigue.
- Noise levels within the suit that do not require hearing protection.
The procurement falls under NAICS code 339999 (All Other Miscellaneous Manufacturing) and Product Service Code 6640. There are no set-aside requirements for this acquisition.
The contracting entity is the NIH OLAO, a federal office within the Department of Health and Human Services. The primary point of contact for this opportunity is Brian Lind ([email protected]). Interested parties should note that the notice is active, with a response deadline of August 21, 2026.
This procurement represents a mission-critical investment in the safety and operational continuity of the nation’s foremost biomedical research and public health institutions. Contractors considering this opportunity should ensure they can meet the highly specialized requirements and volume demands outlined, as well as the compatibility and performance standards essential for BSL-4 laboratory environments.
Further details, including the full list of salient characteristics and safety criteria, are available in the attached solicitation documents accessible via the SAM.gov opportunity listing.